Navigation Links
Elekta Ranks as Top Vendor in MD Buyline Report for 3rd Quarter 2011
Date:10/7/2011

ATLANTA, Oct. 7, 2011 /PRNewswire/ -- For the third quarter of 2011, Elekta continued its domination of the number one ranking in MD Buyline's user satisfaction surveys by earning the top overall composite rankings in all vital business areas: stereotactic radiosurgery (SRS), linear accelerators (tie with another provider), oncology information systems (OIS) and treatment planning systems (TPS). For six consecutive quarters, Elekta has placed first in 23 of 24 quarterly results, trending above the market average for the same time period.

Vendors are rated on a 1 to 10 scale according to user satisfaction with system performance, system reliability, system installation/implementation, applications training, service response time and service repair quality. MD Buyline clinical and IT analysts conduct interviews with hands-on users, including clinicians, physicians, biomedical engineers, physicists, nurses, CIOs and IT managers.

Important details of the Q3 survey include:

  • SRS: Elekta continues to lead the industry, receiving the highest scores in all categories.
  • Linear accelerators: Elekta tied for first with another vendor.
  • OIS: Elekta's MOSAIQ® displaces Varian for the number one ranking and is ranked highest in four of the six performance categories.
  • TPS: Elekta received the highest overall score and the highest score in four of the six categories.

"We're gratified that our clinical users have once again rated our solutions and services as among the very best – it's a trend we intend to continue moving forward," says Jay Hoey, Executive Vice President Elekta North America.

MD Buyline measures user satisfaction based on evaluations by more than 3,300 hospitals in the member network. Founded in 1983, MD Buyline is a market intelligence organization that provides the healthcare industry with independent analysis and reporting.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)
2. Presbyterian Cancer Center to Offer Cancer Patients High-End VMAT Treatments With the Installation of Elekta Infinity
3. Barnes-Jewish Hospital to Provide Gamma Knife Surgery to Additional Patient Groups With New Elekta Technology
4. Elekta / Mitsubishi Electric Collaboration Helps Japans Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
5. Prototype Software from Elektas Research Group Takes First Place in Two Autosegmentation Contests at MICCAI 2010
6. Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer
7. SBRT for Medically Inoperable Early Stage Lung Cancer a Key Topic for Elekta Presenters at Lung Cancer Conference
8. MicroTech Ranks No. 285 on Inc. Magazines 2008 List of the 500 Fastest Growing Private Companies in America
9. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2008 Washington State Technology Fast 50 for 5th Time in Past 7 Years
10. Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine
11. Cadient Group Ranks on Inc. 5000 List of Fastest-Growing Companies for Third Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program ... of his grandfather, “Hire for attitude. Train for skill.” , In keeping with this ... Jevohn Miller as a salesman. Zamzow is hoping to replicate the practice throughout the ...
(Date:2/25/2017)... , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change by ... and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. , ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Chef Jodi ... wine scene. Making stops in several cities, she gained a number of delicious ... began in Stellenbosch, a town in South Africa’s Western Cape province. It is ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
Breaking Biology Technology:
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):